# OMAXE — Omaxe Limited

> Omaxe Limited (OMAXE) on the NSE: 4,712 sessions of split-adjusted history from 2007.

Canonical: https://patternsradar.com/s/OMAXE

## Latest session

- Close: 102.55 INR (-0.59% on the day), 2026-08-21
- Delivery: 36.34% of volume taken to demat (20-day average 42.08%)
- Volume: 10.84L shares, turnover ₹11.1Cr
- Relative volume: 0.43× of its own 20-day average

## Technicals

- RSI(14): 66.93
- ATR(14): 5.46
- SMA 50: 87.32, SMA 200: 78.66
- 52-week range: 62.5 – 108.61 (-5.58% from the high)

## Performance

- 1 week 3.44%, 1 month 18.04%, 3 months 38.3%
- 6 months 32.02%, 1 year 8.59%

## Fundamentals

- Market cap: 1,875.6 crore
- P/E (TTM): — — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): -27.87 INR, split-adjusted to match the price series
- Revenue growth: 43.91% YoY, 16.54% QoQ
- Profit growth: — YoY, — QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | -11.09% | — |
| 3y | 16.74% | — |
| 4y | 20.52% | — |
| 5y | 21.93% | — |
| 6y | 9.05% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 389.2 | 665 | -266.7 | -239.5 | -13.1 | -61.53% |
| 2024-12-31 | 288.9 | 483.1 | -182.7 | -150.3 | -8.23 | -52.01% |
| 2025-03-31 | 541.3 | 710.2 | -157.2 | -148.7 | -8.11 | -27.47% |
| 2025-06-30 | 282.2 | 526.1 | -228.1 | -185.8 | -10.16 | -65.82% |
| 2025-09-30 | 320.8 | 562.8 | -216.5 | -166.4 | -9.11 | -51.87% |
| 2025-12-31 | 301.8 | 519.9 | -200.8 | -153.2 | -8.38 | -50.76% |
| 2026-03-31 | 348.5 | 630 | -253.7 | -191.4 | -10.46 | -54.92% |
| 2026-06-30 | 406.2 | 433.8 | 5.1 | 1.3 | 0.05 | 0.32% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 74.14%
- Public: 25.86%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-12: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_185717_12082026163208_iXBRL_WEB.html
- 2026-07-16: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1694444_16072026055609_WEB.xml
- 2026-05-15: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_158217_15052026215504_iXBRL_WEB.html
- 2026-04-17: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1653014_17042026020308_WEB.xml
- 2026-02-06: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_140872_06022026181316_iXBRL_WEB.html
- 2026-01-16: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1602588_16012026054101_WEB.xml
- 2025-11-14: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_128154_14112025183442_iXBRL_WEB.html
- 2025-10-16: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1550171_16102025033418_WEB.xml

Dated by the day the company broadcast the filing. 110 events are indexed for this instrument.

## About the instrument

- Listed: 2007-08-09 — latest session 2026-08-21 (4,712 sessions)
- ISIN: INE800H01010
- Series: EQ
- Liquidity rank: #694 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/OMAXE.